by Renovia | Jun 17, 2021 | Press Releases
Meet The Company Offering An Innovative Medication-Free Approach To Better Pelvic Floor Health, Bringing Female Urinary Incontinence Out Of The Closet Marija Butkovic 12:26am EDT ForbesWomen I write about innovative tech companies and women behind them. Almost 50% of...
by Renovia | May 25, 2021 | Press Releases
Study shows leva® Digital Therapeutic improves fecal incontinence symptoms Women with accidental bowel leakage experience “significant improvement” in 10-week study NEWS PROVIDED BY Renovia May 25, 2021, 09:00 ET BOSTON, May 25, 2021 /PRNewswire/ —...
by Renovia | Apr 19, 2021 | Press Releases
Renovia raises $17M in Series C-1 financing Proceeds to advance U.S. commercial launch of leva® Digital Therapeutic and additional clinical development Renovia Inc. Apr 19, 2021, 09:00 ET BOSTON, April 19, 2021 /PRNewswire/ — Renovia Inc....
by Renovia | Jan 19, 2021 | Press Releases
Renovia names new president and CEO; completes enrollment for randomized controlled trial Women-led team achieves key milestone ahead of schedule Boston, Mass.—January 19, 2021—Renovia Inc. (“Renovia”), a women-led company that develops digital therapeutics for female...
by Renovia | Dec 1, 2020 | Press Releases
Renovia presents at Piper Sandler Healthcare Conference Medical Technology Disruptors Panel includes Renovia’s leva® Digital Therapeutic, a novel approach for an underreported disorder affecting 20 million women in the U.S. Boston, Mass.—December 1, 2020—Renovia Inc....
by Renovia | Nov 26, 2019 | Press Releases
Boston, MA – November 25, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic device and app technologies for women with pelvic floor disorders, today announced U.S. Food and Drug...
